Pre-Annual General Meeting Information • Oct 2, 2020
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
If you are in any doubt about the action to be taken, you should immediately consult a person authorised under the Financial Services and Markets Act 2000 (FSMA) who specialises in advising on the acquisition of shares and other securities.
If you have sold or otherwise transferred all of your shares in Blackfinch Spring VCT plc (the "Company"), please send this document and accompanying documents, as soon as possible, to the purchaser or transferee or to the stockbroker, authorised financial adviser or other person through whom the sale or transfer was effected for delivery to the purchaser or transferee.
An application has been made to the Financial Conduct Authority ("FCA") for the Ordinary Shares to be issued under the Offer to be listed on the premium segment of the Official List and will be made to the London Stock Exchange for those Ordinary Shares to be admitted to trading on its main market for listed securities.
Howard Kennedy Corporate Services LLP, which is authorised and regulated in the United Kingdom by the FCA, is acting for the Company and no-one else and will not, subject to the responsibilities and liabilities imposed by FSMA or the regulatory regime established thereunder, be responsible to any other person for providing advice in connection with any matters referred to herein.
_________________________________________________________________________________
(Registered in England and Wales with registered number 12166417)
General Meeting in connection with recommended proposals to:
Your attention is drawn to the letter from the Chairman of the Company set out in Part II of this document which contains a unanimous recommendation by your Board to vote in favour of the Resolutions. Your attention is also drawn to the risk factors set out in Part I of this document.
_________________________________________________________________________________
You will find set out at the end of this document a notice of the General Meeting, to be held at 10.00 am on 11 November 2020 to approve the Resolutions.
To be valid, the forms of proxy enclosed with this document for the General Meeting should be returned not less than 48 hours before the meeting (excluding weekends and public holidays), either by post or by hand (during normal business hours only) to the Company's Registrar, The City Partnership (UK) Limited, Suite 2 Park Valley House, Park Valley Mills, Meltham Road, Huddersfield HD4 7BH.
At the time of the publication of this document, restrictions on public gatherings and non-essential travel remain in place as a consequence of the ongoing COVID-19 pandemic. Accordingly the directors of the Company believe it is in the best interests of the Company and its shareholders to hold the General Meeting as a closed meeting with a minimum number of shareholders present. The Company will ensure that the legal requirements to hold the General Meeting are satisfied through the attendance of a minimum number of shareholders and the format of the General Meeting will be purely functional. Unfortunately this means that Shareholders cannot be admitted to the General Meeting . However, the Company strongly encourages Shareholders to vote on the resolutions to be put to the General Meeting by completing a form of proxy in accordance with the instructions set out below. Shareholders are urged to appoint the Chairman as the proxy, as any other appointed person will not be able to access, attend or participate in the General Meeting.
| DIRECTORS, MANAGER AND ADVISERS | 4 | |
|---|---|---|
| PART I | RISK FACTORS | 5 |
| PART II | LETTER FROM THE CHAIRMAN | 6 |
| PART III | ADDITIONAL INFORMATION | 10 |
| PART IV | DEFINITIONS | 16 |
| NOTICE OF THE GENERAL MEETING | 19 |
| Directors (all non-executive) | Peter Lionel Raleigh Hewitt (Chairman) Katie Jones Dr Reuben Wilcock |
|---|---|
| all of (registered office, at) | 1350-1360 Montpellier Court Gloucester Business Park Brockworth Gloucester Gloucestershire GL3 4AH |
| Investment Manager | Blackfinch Investments Limited 1350-1360 Montpellier Court Gloucester Business Park Brockworth Gloucester Gloucestershire GL3 4AH |
| VCT Tax Adviser | Philip Hare & Associates LLP Hamilton House 1 Temple Avenue London EC4Y 0HA |
| Sponsor | Howard Kennedy Corporate Services LLP No. 1 London Bridge London SE1 9BG |
| Auditors | BDO LLP 150 Aldersgate Street London EC1A 4AB |
| Solicitors | Howard Kennedy LLP No. 1 London Bridge London SE1 9BG |
| Registrars and Receiving Agents | The City Partnership (UK) Limited Suite 2 Park Valley Mills Park Valley House Meltham Road Huddersfield HD4 7BH |
Shareholders should consider carefully the following risk factors in addition to the other information presented in this document. If the risks described below were to occur, they could have a material effect on the Company's business, financial condition or results of operations. The risks and uncertainties described below are not the only ones the Company, the Board or Shareholders will face in relation to the proposals set out in this document. Additional risks not currently known to the Company or the Board, or that the Company or the Board currently believe are not material in relation to such proposals, may also adversely affect the Company's business, financial condition or results of operations. Shareholders should consult a person authorised under FSMA who specialises in advising on investments in shares and other securities in respect of the matters under consideration in this document.
Completion of the Offer is dependent upon the approval by Shareholders of Resolutions 1 to 3 to be proposed at the General Meeting. There can be no guarantee that this condition will be satisfied and, if all of these Resolutions are not passed, the Offer will be withdrawn and the Company will be responsible for the costs of the proposals relating to the Offer.
As envisaged by the investment policy of the Company, it is intended that risk will be spread by investing in a number of different businesses within different industry sectors using a mixture of securities. The maximum amount currently permitted to be invested in any one company (inclusive of any related group company) is limited to 15% of the value of the portfolio, at the time of investment , in accordance with the VCT legislation. If the Offer does not proceed and the Company is not able to raise further funds, this will may prevent the Company from creating a more diversified portfolio of investments and inhibit the Company from taking advantage of attractive investment opportunities it believes will become available as the UK economy emerges from the current pandemic, and also create a less diversified portfolio than otherwise thereby increasing the risk to investors.
(Registered in England and Wales with registered number 12166417)
Directors:
Peter Lionel Raleigh Hewitt (Chairman) Katie Jones Reuben Wilcock
Registered Office:
1350-1360 Montpellier Court Gloucester Business Park Brockworth Gloucester Gloucestershire GL3 4AH
2 October 2020
Dear Shareholder,
Proposals to approve the payment of the Investment Adviser Promoter Fees; authorise the issue of the Ordinary Shares whilst disapplying pre-emption rights; authorise the purchase of Shares, and approve the cancellation of the Company's share premium account.
I am pleased to announce that the Company is seeking to raise up to £20 million, before expenses, by way of an offer for subscription for Ordinary Shares to existing and new shareholders and I am writing to you because the Ordinary Share issue requires your approval. The Company's share offer, launched on 11 November 2019, raised more than £3.9 million (before issue costs). Your board believes that the proposed Ordinary Share issue is in the best interests of all Shareholders as it will lead to both economies of scale as well as greater diversification in the Company's portfolio of investments, as we have an exciting pipeline of investment opportunities.
This document explains the proposal to grant authority to issue the Ordinary Shares whilst disapplying pre-emption rights, which are being needed to facilitate the Offer, a proposed authority for the Company to purchase its Shares, both of which are required to be approved by Shareholders under company law and a proposal to pay a fee to the Company's investment manager, for promoting the Offer, which is required to be approved by Shareholders under the Listing Rules.
The Company is seeking to raise £20 million, with an over-allotment facility of £10 million, through the Offer which will open today. Application will be made for all of the Ordinary Shares issued under the Offer to be admitted to trading on the London Stock Exchange's main market for listed securities. The net proceeds of the Offer will be applied in accordance with the Company's published investment policy, which is to invest in early stage high-growth technology-enabled companies. The Company will be in a strong position to provide follow on investment to companies in the Blackfinch Ventures EIS Portfolios which are managed by the Company's investment adviser, Blackfinch thereby benefiting from Blackfinch's deep knowledge, experience and past data on those companies.
Since the outbreak of Covid 19 our investment manager, Blackfinch, has been inundated with exciting investment proposals from a number of UK businesses which because they have performed strongly over the period of the pandemic, are looking for further capital to fuel their growth. In addition, some of Blackfinch's existing portfolio companies have successfully adapted to the changing market conditions and now offer high tech products and services which suits the needs of the times, positioning them well for further investment.
Blackfinch has a 25-year heritage driven by a management team who have extensive experience across sectors including SEIS, EIS, VCT, renewables, property and AIM securities. Run by a team of 5 investment professionals, Blackfinch Ventures is supported by the wider Blackfinch Group and an external network of experienced founders, industry leaders and experts, called the UltraNEDs. Collectively, these individuals give access to over 150 years of experience of investing in, mentoring and running early stage companies. As at 28 September 2020 Blackfinch had over £420 million of funds under management and administration.
Shareholders are asked to authorise the Board to allot the Ordinary Shares pursuant to the Offer whilst disapplying pre-emption rights, under CA 2006, which are the subject of Resolutions 1 and 3.
As is customary in the VCT sector Blackfinch charges the VCT a fee for raising funds. In respect of the Offer it is proposed that Blackfinch be appointed as the promoter, and that the Company pay Blackfinch a Promoter Fee, for its role as promoter, amounting to 2.5% of the monies subscribed for Shares under the Offer less any discounts for early investment ("Promoter Fee"). For direct investors and investors not receiving financial advice and who are introduced through an execution only broker, it will charge an additional 3% (in respect of direct investors, or up to 3% in respect investors introduced through an execution only broker) of the monies subscribed for Shares under the Offer), less any discounts for early investment ("Direct Investor Premium") (the Director Investor Premium and the Promoter Fee together being the "Investment Adviser Promoter Fees"). The Investment Adviser will also pay Blackfinch 0.5% of the value of the Investor's portfolio per annum ("Direct Investor Ongoing Fee") out of its Annual Advisory Fee in consideration for promoting the Offer. Blackfinch will be responsible for the payment of initial commission to authorised financial intermediaries in respect of execution only clients.
Accordingly, under an offer agreement (the "2020 Offer Agreement") dated 2 October 2020 between the Company, the Directors, Howard Kennedy and Blackfinch, Blackfinch will, subject to the passing of Resolution 2 at the General Meeting, receive the Investment Adviser Promoter Fees, out of which, Blackfinch will discharge the costs of the Offer.
The payment of Investment Adviser Promoter Fees is a related party transaction under the Listing Rules, being a transaction between the Company and Blackfinch, its investment manager and as such, is required to be approved by the Shareholders at the General Meeting, under the Listing Rules. This is the subject of Resolution 2.
Although the existing Ordinary Shares are, and the Ordinary Shares issued under the Offer will be, listed, Shareholders may find it difficult to sell their Shares and, therefore, to improve liquidity, the Company has established a buy-back policy for the Shares subject to the requirements of the Listing Rules. As a guide and subject to the Board's discretion and providing that, in the opinion of the Board, there is adequate surplus cash available, the Company will consider buying back Shares at up to a 5% discount to the last published NAV. The approval of the authority for the Company to buy back Shares is the subject of Resolution 4, and is required under CA 2006.
Notice of the General Meeting is set-out at the end of this document. The General Meeting will be held at 10.00 am on 11 November 2020 as a closed meeting. The Offer is conditional upon Resolutions 1 to 3 being passed at the General Meeting.
An explanation of the Resolutions is set out below:
Resolution 1 is an ordinary resolution and seeks the approval of Shareholders to authorise the Directors pursuant to Section 551 CA 2006 to allot Ordinary Shares up to an aggregate nominal value of £400,000 (representing approximately 1000% of the issued share capital of the Company as at 1 October 2020, this being the latest practicable date prior to publication of this document) in connection with the Offer and other offers for subscription. The authority conferred by this Resolution 1 will expire at the conclusion of the Company's next annual general meeting or on the expiry of fifteen months following the passing of this Resolution 1, whichever is the later (unless previously renewed, varied or revoked by the Company in general meeting).
Resolution 2 is an ordinary resolution to approve the payment of the Investment Adviser Promoter Fees to Blackfinch, details of which are set out under the heading "2020 Offer Agreement" on page 7, in accordance with the Listing Rules as Blackfinch is a related party under those rules. Blackfinch is not a Shareholder and will not, therefore, vote on this Resolution 2 at the General Meeting and, as a related party to the Company under the Listing Rules, has undertaken to take all reasonable steps to ensure that its associates (as defined in the Listing Rules)will not vote on this Resolution 2 at the General Meeting.
Resolution 3 is a special resolution and seeks the approval of Shareholders to dis-apply pre-emption rights in respect of any Ordinary Shares issued pursuant to the authority contained in Resolution 1, in accordance with CA 2006 (up to an aggregate nominal value of £400,000, which represents 1000% of the issued share capital of the Company as at 1 October 2020, this being the latest practicable date prior to publication of this document). The authority conferred by Resolution 3 will expire at the conclusion of the Company's next annual general meeting or on the expiry of fifteen months following the passing of this Resolution 3, whichever is the later (unless previously renewed, varied or revoked by the Company in general meeting).
The authorisations conferred by Resolutions 1 and 3 will be used to enable the Company to issue Ordinary Shares under the Offer and other smaller share offers.
Resolution 4 is a special resolution and seeks the approval of Shareholders to authorise the Company to make market purchases pursuant to CA 2006 of up to such number of Ordinary Shares as is equal to 14.99% of the issued Ordinary Shares immediately following the closing of the Offer. Any Shares bought back under this authority may be cancelled or held in treasury as may be determined by the Board. The authority conferred by Resolution 4 will expire at the conclusion of the Company's next annual general meeting or on the expiry of fifteen months following the passing of Resolution 4, whichever is the later (unless previously renewed, varied or revoked by the Company in general meeting).
Resolution 5 is a resolution to cancel the share premium account of the Company at the date an order is made confirming such cancellation by the Court, to create a pool of distributable reserves, in accordance with the CA 2006.
The ordinary Resolutions require the approval of a simple majority of 50% of the votes cast in respect of them. The special Resolutions require the approval of 75% of the votes cast in respect of them.
However, before taking any action, you are recommended to read the further information set out in this document and to seek advice from your Independent Financial Adviser.
Shareholders will find enclosed with this document the form of proxy for use at the General Meeting. Whether or not you propose to attend the General Meeting, you are requested to complete and return the relevant forms of proxy so as to be received not less than 48 hours before the time appointed for holding of the General Meeting (excluding weekends and public holidays). Completion and return of a form of proxy will not prevent you from attending and voting in person at the General Meeting should you wish to do so.
At the time of the publication of this document, restrictions on public gatherings and non-essential travel remain in place as a consequence of the ongoing COVID-19 pandemic. Accordingly the directors of the Company believe it is in the best interests of the Company and its shareholders to hold the General Meeting as a closed meeting with a minimum number of shareholders present. The Company will ensure that the legal requirements to hold the General Meeting are satisfied through the attendance of a minimum number of shareholders and the format of the General Meeting will be purely functional. Unfortunately this means that Shareholders cannot be admitted to the General Meeting . However, the Company strongly encourages Shareholders to vote on the resolutions to be put to the General Meeting by completing a form of proxy in accordance with the instructions set out below. Shareholders are urged to appoint the Chairman as the proxy, as any other appointed person will not be able to access, attend or participate in the General Meeting Recommendation
Your Board believes that the proposals described in this Circular, including the Resolutions, are in the best interests the Shareholders as a whole.
Adviser Promoter Fees.
The Board also considers that the payment of the Investment Adviser Promoter Fees is fair and reasonable so far as the Shareholders are concerned and has been so advised by Howard Kennedy, as sponsor to the Company. In providing this advice, Howard Kennedy has taken into account the Directors' commercial assessment of the terms of the 2020 Offer Agreement relating to the payment of the Investment Adviser Promoter Fees.
Accordingly, the Board unanimously recommends Shareholders to vote in favour of the Resolutions at the General Meeting. Blackfinch has undertaken to take all reasonable steps to ensure that its Associates will not vote on Resolution 2 at the General Meeting.
Yours sincerely
Peter LR Hewitt, Chairman
Blackfinch Spring VCT plc
The Company and the Directors, whose names appear on page 4, accept responsibility for the information contained in this document. To the best of the knowledge and belief of the Company and the Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this document is in accordance with the facts and does not omit anything likely to affect the import of such information.
2.1 As at 1 October 2020 (being the latest practicable date prior to the publication of this document), the issued ordinary share capital of the Company was as follows:
| Aggregate nominal | Number of Shares |
|---|---|
| value (£) |
£331,176.70 33,117,670
2.2 As at 1 October 2020 (being the latest practicable date prior to the publication of this document), no warrants or options to subscribe for Ordinary Shares are outstanding, nor did the Company hold any share capital in treasury.
3.1 As at the date of this document the Directors, their immediate families and connected persons within the meaning of Rule 3 of the Disclosure Guidance and Transparency Rules ("DTR 3") have, and, assuming (i) the Offer is fully subscribed (assuming the over-allotment facility is fully utilised) at an Offer Price of £1.027 and (ii) that the fees payable to the Promoter are 5.5%, the Directors and their immediate families and connected persons within the meaning of DTR 3 will immediately following the Offer have the following interests in the share capital of the Company, the existence of which is known to or could with reasonable diligence be ascertained by the Directors:
| Number of Ordinary Shares before the Offer |
% of issued Ordinary Shares before the Offer |
|
|---|---|---|
| Peter L R Hewitt | 5,000 | 0.13% |
| Katie Jones | 0 | 0% |
| Reuben Wilcock | 0 | 0% |
| Number of Ordinary Shares following the Offer |
% of issued Ordinary Shares following the Offer |
|
| Peter L R Hewitt | 5,000 | 0.015% |
| Katie Jones | 0 | 0% |
Save for the persons set out below, the Company is not aware of any person, not being a member of its administrative, management or supervisory bodies who, as at the date of this document, is directly or indirectly, interested in 3% or more of the issued share capital of the Company and is required to notify such interest in accordance with the Disclosure Guidance and Transparency Rules or who directly or indirectly controls the Company.
| Substantial Shareholder | Number of Ordinary Shares |
% of issued Ordinary Shares |
|---|---|---|
| R. Hensman | 200,000 | 5.11% |
| R. L. Carter | 200,000 | 5.11% |
| C. J. Brown | 197,000 | 5.04% |
| R. Lewis | 196,020 | 5.01% |
| G. G.McArthur | 126,750 | 3.24% |
5.1 The following are (a) the only contracts, not being contracts entered into in the ordinary course of business, that have been entered into by the Company since incorporation and which are or may be material to the Company, and (b) the only contracts, not being contracts entered into in the ordinary course of business, that have been entered into by the Company since incorporation and which contain any provisions under which the Company has any obligation or entitlement which are material to the Company as at the date of this document:
5.1.1 An offer agreement dated 2 October 2020 and made between the Company (1), the Directors (2), Blackfinch (3) and the Sponsor (4), (the "2020 Offer Agreement") pursuant to which the Sponsor has agreed to act as sponsor to the Offer and Blackfinch has undertaken, as agent of the Company, to use its reasonable endeavours to procure subscribers for Ordinary Shares under the Offer. Under the Offer Agreement, the Company will pay Blackfinch a commission of up to 5.5% of the value of each accepted application for Ordinary Shares received pursuant to the Offer (plus VAT, if applicable).
Blackfinch will be responsible for the payment of initial commission to authorised financial intermediaries in respect of execution only clients.
Under the 2020 Offer Agreement, which may be terminated by the parties in certain circumstances, the Company, Blackfinch and the Directors have given certain warranties and indemnities. Warranty claims must be made by no later than three months after the date of the second annual general meeting of the Company following the closing date of the Offer at which Shareholders approve the Company's accounts or (if earlier) by the date the Company is subject to a takeover. The Company has also agreed to indemnify the Sponsor in respect of its role as Sponsor and under the Offer Agreement. The warranties and indemnities are in usual form for a contract of this type and the warranties are subject to limits of one year's director fees for each Director. The Offer Agreement may be terminated, inter alia, if any statement in the Prospectus is untrue, any material omission from the Prospectus arises or any breach of warranty occurs.
5.1.2 An Offer Agreement dated 11 November 2019 and made between the Company (1), the Directors (2), Blackfinch (3) and the Sponsor (4), (the "2019 Offer Agreement") pursuant to which the Sponsor agreed to act as sponsor to the 2019 Offer and Blackfinch undertook, as agent of the Company, to use its reasonable endeavours to procure subscribers for Ordinary Shares under the 2019 Offer. Blackfinch was entitled to any interest earned on subscription monies prior to the allotment of Ordinary Shares. Under the 2019 Offer Agreement, the Company agreed to pay Blackfinch a commission of up to 5.5% of the value of each accepted application for Ordinary Shares received pursuant to the 2019 Offer (plus VAT, if applicable).
Blackfinch was responsible for the payment of initial commission to authorised financial intermediaries in respect of execution only clients under the 2019 Offer.
Under the 2019 Offer Agreement, which could be terminated by the parties in certain circumstances, the Company, Blackfinch and the Directors gave certain warranties and indemnities. Warranty claims must be made by no later than three months after the date of the second annual general meeting of the Company following the closing date of the 2019 Offer at which Shareholders approve the Company's accounts or (if earlier) by the date the Company is subject to a takeover. The Company also agreed to indemnify the Sponsor in respect of its role as Sponsor under the 2019 Offer Agreement. The warranties
and indemnities are in usual form for a contract of this type and the warranties are subject to limits of one year's director fees for each Director The 2019 Offer Agreement could be terminated, inter alia, if any statement in the prospectus for the 2019 Offer was untrue, any material omission from that prospectus arose or any breach of warranty occurred.
5.1.3 An agreement (the "Investment Advisory Agreement") dated 11 November 2019 and made between the Company and Blackfinch whereby Blackfinch will, with effect from the first date on which the Company resolves to allot Shares pursuant to the 2019 Offer (the "Effective Date"), be appointed as the Company's investment Adviser to provide discretionary investment Advisory services to the Company in respect of its portfolio of Qualifying Investments and Non-Qualifying Investments.
Blackfinch will receive an annual fee equal to 2.5% of the Net Asset Value (plus VAT if applicable) payable quarterly in arrears.. Blackfinch is entitled to reimbursement of expenses incurred in performing its duties under the Agreement, and will also be entitled to receive and retain transaction and introductory fees, directors' fees, monitoring fees, consultancy fees, corporate finance fees, syndication fees, exit fees and commissions in relation to portfolio companies.
The Investment Adviser will also be entitled to a performance incentive fee payable in relation to each accounting period, subject to the Performance Value per Share being at least 130p at the end of the relevant accounting period. The amount of the performance incentive fee will be equal to 20% of the amount by which the Performance Value per Share at the end of an accounting period exceeds the High Water Mark and multiplied by the number of Shares in issue at the end of the relevant period.
The appointment of the Investment Adviser will continue unless and until terminated by either party giving to the other not less than 12 months' notice in writing, such notice not to take effect before the end of the fifth anniversary following the last allotment of Shares pursuant to an offer for subscription made by the Company. The Investment Advisory Agreement is subject to earlier termination by either party in certain circumstances.
The Investment Adviser has agreed to indemnify the Company by such amount as is equal to the excess by which the Annual Running Expenses of the Company exceeds 3.5% of the Net Asset Value, calculated on an annual basis
The provision by the Investment Adviser of discretionary investment Advisory services is subject to the overall control, direction and supervision of the Directors.
Directors' Letters of Appointment
5.1.4 Each of the Directors entered into an agreement with the Company, dated 11 November 2019 in the case of Katie Jones and Peter Hewitt and 18 September 2020 in the case of Reuben Wilcock, as referred to in paragraph 3.2 above whereby he or she is required to devote such time to the affairs of the Company as the Board reasonably requires consistent with their role as non-executive director. Peter Hewitt is entitled to receive an annual fee of £18,000 (increasing to £20,000 if more than £5m was raised under the 2019 Offer) (plus VAT if applicable), Katie Jones is entitled to receive an annual fee of £18,000 (plus VAT if applicable) and for the services to be provided by Reuben Wilcock , Blackfinch is entitled to receive an annual fee of £12,000 (plus VAT if applicable). Each party can terminate the agreement by giving to the other at least six months' notice in writing to expire at any time after the date 15 months from the respective commencement dates. No benefits are payable on termination.
5.1.5 An agreement dated 11 November 2019 and made between the Company and Blackfinch (the "Administration Agreement"), whereby Blackfinch will provide certain administration services and company secretarial services to the Company with regard to all the investments of the Company, for an annual fee of the higher of 0.3% of Net Asset Value of £60,000 (plus VAT if applicable).
The Administration Agreement will continue unless and until terminated by either party giving to the other not less than 12 months' notice in writing, such notice not to take effect before the end of the fifth anniversary following the last allotment of Shares pursuant to an offer for subscription made by the Company, but subject to early termination in certain circumstances.
5.1.6 A custody agreement dated 11 November 2019 between the Company and Blackfinch (the "Custody Agreement") under which Blackfinch agrees to hold securities in certificated form on behalf of the Company as custodian for an annual fee of £5,000 plus VAT, terminable by either party giving to the other not less than 12 months' notice in writing, such notice not to take effect before the end of the fifth anniversary following the last allotment of Shares pursuant to an offer for subscription made by the Company, but subject to early termination in certain circumstances
Company for which unaudited financial information has been published) to the date of this document..
2 October 2020
| "2019 Offer" | the offer for subscription by the Company for Ordinary Shares in respect of the tax years 2018/19 and 2019/20 that was launched on 11 November 2019 |
|---|---|
| "2020 Offer Agreement" | the offer agreement dated 2 October 2020, between the Company, the Directors, Howard Kennedy and Blackfinch |
| "Annual Advisory Fee" | the annual fee payable to Blackfinch under the Investment Advisory Agreement |
| "Annual Running Expenses" | the central running costs of the Company, including Directors' fees, the annual investment Advisory fee and the administration fee but excluding transaction related fees and expenses, any performance incentive and costs relating to the establishment of the Company and any annual trail commissions payable by or on behalf of the Company. |
| "Articles" | the articles of association of the Company, as amended from time to time |
| "Associates" | has the meaning given in the Listing Rules |
| "Blackfinch" or "the Investment Adviser" |
Blackfinch Investments Limited of 1350-1360 Montpellier Court, Gloucester Business Park, Gloucester GL3 4AH |
| Blackfinch Ventures EIS Portfolios |
the discretionary portfolio service that is managed and administered by the Investment Adviser and which provides a portfolio of investments in unquoted technology companies that meet the qualification requirements for enterprise investment scheme relief under the ITA |
| "Board" or "Directors" | the board of directors of the Company |
| "Business Days" | any day (other than a Saturday) on which the clearing banks are open for normal banking business in sterling |
| "CA 2006" | Companies Act 2006 (as amended) |
| "Circular" | this document |
| "the Company" or the "Company" |
Blackfinch Spring VCT plc |
| "Disclosure Guidance & Transparency Rules" |
the disclosure guidance & transparency rules of the FCA |
| "EIS" | the Enterprise Investment Scheme, satisfying the requirements of Part 5 of ITA 2007 |
| "FCA" | the Financial Conduct Authority |
| "FSMA" | the Financial Services and Markets Act 2000 (as amended) |
|---|---|
| "General Meeting" | the general meeting of the Company convened for 11 November 2020 (or any adjournment thereof) |
| "High Water Mark" | the higher of 130p and the highest Performance Value per Share at the end of any previous accounting period |
| "Howard Kennedy" | Howard Kennedy Corporate Services LLP |
| "Independent Shareholders" | Shareholders other than Blackfinch and its Associates |
| "Initial Adviser Charge" | the initial charges payable to advisers in connection with the Offer |
| "Investor" | a subscriber for Ordinary Shares under the Offer |
| "ITA 2007" | Income Tax Act 2007 (as amended) |
| "Listing Rules" | the listing rules of the FCA |
| "London Stock Exchange" | London Stock Exchange plc |
| "NAV" or "net asset value" | net asset value |
| "Non-Qualifying Investments" | those investments specified in section 274 ITA |
| "Offer" | the offer for subscription by the Company as referred to on pages 6 and 7 |
| "Official List" | the official list of the FCA |
| "Ordinary Shares" | Ordinary Shares of 1p each in the capital of the Company (and each a "Share") |
| in relation to each accounting period of the Company, the total of the following: |
|
| (i) the NAV; |
|
| "Performance Value per Share" | (ii) all performance incentive fees previously paid or accrued by the Company to the Investment Adviser for all previous accounting periods; and |
| (iii) the cumulative amount of dividends paid by the Company before the relevant accounting reference date (including the amount of those dividends in respect of which the ex-dividend date has passed as at that date); |
|
| divided by the number of Shares in issue in the Company on the relevant date. |
|
| "Promoter Fee" | the initial fee payable by the Company to Blackfinch for promoting the Offer, details of which are set out on page 7 |
| "Prospectus" | the prospectus issued by the Company dated 2 October 2020 |
|---|---|
| "Qualifying Investment" | an investment in an unquoted company or stocks which are AIM/NEX- traded which satisfies the requirements of Chapter 4 of Part 6 ITA, as described in Part 2 of this document |
| "Resolutions" | the resolutions to be proposed at the General Meeting |
| "Shareholder" | a holder of Ordinary Shares |
| "UK" | the United Kingdom |
| "VCT" or "venture capital trust" |
a company satisfying the requirements of Chapter 3 of Part 6 of ITA 2007 for venture capital trusts |
| "VCT Rules" | Part 6 ITA 2007 and every other statute (including any orders, regulations or other subordinate legislation made under them) for the time being in force concerning VCTs |
NOTICE IS HEREBY GIVEN that a General Meeting of Blackfinch Spring VCT plc ("the Company") will be held at 10.00 am on 11 November 2020 for the purposes of considering and, if thought fit, passing the following resolutions, which will be proposed as to resolutions 1 and 2 as ordinary resolutions and as to resolutions 3 and 4 as special resolutions:
the day on which such Ordinary Share is to be purchased; and (ii) the amount stipulated by Article 5(6) of Market Abuse Regulation (596/2014/EU);
For the purpose of these Resolutions, words and expressions defined in the Circular shall have the same meanings in these Resolutions, save where the context requires otherwise.
Dated 2 October 2020
By order of the Board Registered Office:
Peter LR Hewitt (Chairman) 1350-1360 Montpellier Court Gloucester Business Park Brockworth Gloucester Gloucestershire GL3 4AH
Information regarding the General Meeting, including the information required by section 311A of CA 2006, is available from: 1350-1360 Montpellier Court, Gloucester Business Park, Brockworth, Gloucester, Gloucestershire, GL3 4AH. Notes:
a) Any member of the Company entitled to attend and vote at the General Meeting is also entitled to appoint one or more proxies to attend, speak and vote instead of that member. A member may appoint more than one proxy in relation to the General Meeting provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that member. A proxy may demand, or join in demanding, a poll. A proxy need not be a member of the Company but must attend the General Meeting in order to represent his appointor. A member entitled to attend and vote at the General Meeting may appoint the Chairman or another person as his proxy although the Chairman will not speak for the member. However, the General Meeting will be held as a closed meeting with a minimum number of shareholders present. The Company will ensure that the legal requirements to hold the meeting are satisfied through the attendance of a minimum number of Directors and/or employee shareholders and the format of the meeting will be purely functional. Neither shareholders nor their proxies (other than the Chairman) will therefore be admitted to the General Meeting. The Company therefore strongly encourages Shareholders to vote on the resolutions to be put to the General Meeting by completing a form of proxy appointing the Chairman as their proxy, as any other appointed person will not be able to access, attend or participate in the General Meeting.. If you are not a member of the Company but you have been nominated by a member of the Company to enjoy information rights, you do not have a right to appoint any proxies under the procedures set out in these Notes. Please read Note (i) below. Under section 319A of the CA 2006, the Company must answer any question a member asks relating to the business being dealt with at the General Meeting unless:
Members of the Company as at 5pm on 9 November 2020 or, in the event that the General Meeting is adjourned, on the Register of Members at close of business two days prior to any adjourned meeting, shall be entitled to attend and vote at the General Meeting in respect of such shares registered in their name at the relevant time. Changes to entries on the Register of Members after 5pm on 9 November 2020 or, in the event that the General Meeting is adjourned, on the Register of Members after close of business two days prior to any adjourned meeting, shall be disregarded in determining the right of any person to attend and vote at the General Meeting.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.